“METASTATIC CHOLANGIOCARCINOMA AS A TARGET OF MOLECULAR-DIRECTED THERAPY” (2018) Voprosy onkologii, 64(5), pp. 671–677. doi:10.37469/0507-3758-2018-64-5-671-677.